Serum Pepsinogens in Gastric Cancer Screening
- 29 April 2010
- journal article
- editorial
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 55 (8), 2123-2125
- https://doi.org/10.1007/s10620-010-1248-8
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Predictive Power of Serum Pepsinogen Tests for the Development of Gastric Cancer in Comparison to the Histologic Risk IndexDigestive Diseases and Sciences, 2010
- Pathology of Gastric Intestinal Metaplasia: Clinical ImplicationsAmerican Journal of Gastroenterology, 2010
- Validation of the pepsinogen test method for gastric cancer screening using a follow-up studyGastric Cancer, 2009
- The Validity of a Biomarker Method for Indirect Detection of Gastric Mucosal Atrophy Versus Standard HistopathologyDigestive Diseases and Sciences, 2009
- Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohortGut, 2009
- Non-invasive tests in gastric diseasesDigestive and Liver Disease, 2008
- Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda studyScandinavian Journal of Gastroenterology, 2008
- Serum Pepsinogen Levels,Helicobacter pyloriCagA Status, and Cytokine Gene Polymorphisms Associated with Gastric Premalignant Lesions in Costa RicaCancer Epidemiology, Biomarkers & Prevention, 2007
- Gastric cancer screening using the serum pepsinogen test methodGastric Cancer, 2006
- Epidemiology of gastric cancer in JapanPostgraduate Medical Journal, 2005